Cargando…
From cervical cancer elimination to eradication of vaccine-type human papillomavirus: Feasibility, public health strategies and cost-effectiveness
The Director-General of the World Health Organization has called for global action towards elimination of cervical cancer as a public health problem. Cervical cancer is caused by human papillomavirus (HPV), an infectious agent with no non-human reservoir. One way to achieve this is through very high...
Autores principales: | Jit, Mark, Prem, Kiesha, Benard, Elodie, Brisson, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957342/ https://www.ncbi.nlm.nih.gov/pubmed/33309871 http://dx.doi.org/10.1016/j.ypmed.2020.106354 |
Ejemplares similares
-
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical modelling analysis
por: Bénard, Élodie, et al.
Publicado: (2022) -
Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis
por: Prem, Kiesha, et al.
Publicado: (2023) -
Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
por: Drolet, Mélanie, et al.
Publicado: (2021) -
Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model
por: Jit, Mark, et al.
Publicado: (2015) -
Human papillomavirus vaccination strategies for accelerating action towards cervical cancer elimination
por: Shet, Anita, et al.
Publicado: (2023)